{"output": [["Incyte Corp", "COMP", "Enter", "Syros Pharmaceuticals", "COMP"], ["Incyte Corp", "COMP", "Control", "Therapies", "PRODUCT"], ["Syros", "COMP", "Use", "Gene Control Platform", "CONCEPT"], ["Syros", "COMP", "Identify", "Therapeutic Targets", "CONCEPT"], ["Incyte Corp", "COMP", "Operate_In", "Myeloproliferative Neoplasms", "SECTOR"], ["Incyte Corp", "COMP", "Have", "Exclusive Worldwide Rights", "NONE"], ["Incyte Corp", "COMP", "Develop", "Therapies", "PRODUCT"], ["Incyte Corp", "COMP", "Commercialize", "Therapies", "PRODUCT"], ["Incyte Corp", "COMP", "Get", "Intellectual Property", "CONCEPT"], ["Incyte Corp", "COMP", "Pay", "Syros", "COMP"], ["Syros", "COMP", "Receive", "Upfront", "FIN_INSTRUMENT"], ["Syros", "COMP", "Receive", "Stock", "FIN_INSTRUMENT"], ["Syros", "COMP", "Exercise", "Options", "NONE"], ["Syros", "COMP", "Get", "Target Selection", "NONE"], ["Syros", "COMP", "Get", "Option Exercise Fees", "NONE"], ["Syros", "COMP", "Receive", "Development Milestones", "NONE"], ["Syros", "COMP", "Receive", "Regulatory Milestones", "NONE"], ["Syros", "COMP", "Receive", "Commercial Milestones", "NONE"], ["Syros", "COMP", "Eligible", "Royalties", "NONE"]], "published": "2018-01-08T21:20:00.000+02:00"}